ATOSSA THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
ATOSSA THERAPEUTICS, INC. (ATOS) had Stock Issued During Period, Shares, New Issues of 125.00 thousand shares as of 2017-06-29, per its 10-K filed 2019-03-28.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2019-03-28
- 2017-06-29: Stock Issued During Period, Shares, New Issues 125.00K shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2017-06-29 | 125.00K shares 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |